Zachary Drew Epstein-Peterson MD

PubMed

• 7 citations
  Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma.
  Pallawi Torka, Tatyana Feldman, Kerry J Savage, Nivetha Ganesan, Esther Drill
  Journal of Clinical Oncology. 2025-03-10
• 5 citations
  Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experience.
  Giulio Cassanello, Esther Drill, Alfredo Rivas-Delgado, Michelle Okwali, Irem Isgor
  Haematologica. 2025-02-01
• 8 citations
  Cutaneous T-cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomes.
  Robert Stuver, Stephen Dusza, Zachary D Epstein-Peterson, Paola Ghione, Steven M Horwitz
  Journal of the European Academy of Dermatology and Venereology. 2025-02-01

Abstracts/Posters

• RAS Mutations Are Independently Associated with Decreased Overall Survival
  Zachary D. Epstein-Peterson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• 'Contemporary Outcomes in HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• De Novo Myelodysplastic Syndromes in Patients 20-50 Years Old Characterized 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• 'Dual Driver Mutant BCR-ABL1-Negative Myeloid Neoplasms: Multicenter Clinicopathologic 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019